Page last updated: 2024-10-27

flurbiprofen and Day Blindness

flurbiprofen has been researched along with Day Blindness in 2 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonald, MB1
Wyse, TB1
Borodkin, MJ1
Ocmand, A1
Shoelson, B1
Thompson, H1
Zollman, TM1
Bragg, RM1
Harrison, DA1

Trials

2 trials available for flurbiprofen and Day Blindness

ArticleYear
Comparison of the effectiveness of 4 anti-inflammatory drops in relieving photophobia after pupil dilation.
    Journal of cataract and refractive surgery, 1999, Volume: 25, Issue:3

    Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Bl

1999
Clinical effects of oleoresin capsicum (pepper spray) on the human cornea and conjunctiva.
    Ophthalmology, 2000, Volume: 107, Issue:12

    Topics: Adult; Analgesics; Anesthetics, Local; Conjunctiva; Cornea; Female; Flurbiprofen; Humans; Male; Midd

2000